Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy

Name: Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy
License: Public Domain

Latin American Cooperative Oncology Group

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

bladder cancer, urothelial carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 217036
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.